“What Am I — Qualia, Brahman, Neurons, or just Nothing?”
Exploring the intersection of psychopharmacology, neuroscience, and non-dual phenomenology. This node details the therapeutic benefits of psychedelics (psilocybin, DMT, LSD) for mental health illnesses, the neural mechanism of serotonin 5-HT2A receptor agonism, and how chemical states induce temporary 'ego-death' experiences that mirror classical non-dual realization.
Clinical trials from institutions like Johns Hopkins and Imperial College London show that substances like psilocybin and DMT can cause rapid, sustained reductions in treatment-resistant depression, anxiety, and PTSD. By promoting neuroplasticity (synaptogenesis) and increasing brain connectivity, they help break rigid, maladaptive cognitive loops.
Classic psychedelics act primarily as agonists at the 5-HT2A serotonin receptor. This stimulation leads to a dramatic suppression of the Default Mode Network (DMN)—the brain's self-referential 'ego center'. As the DMN's gating mechanism shuts down, regions of the brain that do not normally talk to each other communicate directly, creating a highly integrated global workspace.
At high doses, particularly with DMT or high-dose psilocybin, the brain's predictive self-model dissolves completely. The subjective boundary between 'self' and 'universe' collapses (ego-death), leading to a temporary state of raw, undivided awareness that closely aligns with the insights of Non-Dual Realization and deep meditation.